Bill

Bill > HR447


US HR447

Affordable and Safe Prescription Drug Importation Act


summary

Introduced
01/10/2019
In Committee
01/25/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

AI Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe prescription drugs by wholesale distributors, pharmacies, and individuals. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days to permit the importation of qualifying prescription drugs from Canada. After two years, the FDA may also permit the importation of qualifying drugs from other countries that have comparable drug approval standards. The bill establishes a process for certifying foreign sellers, including licensed foreign pharmacies and foreign wholesale distributors, and imposes additional criteria they must meet to participate in the importation program. The bill also prohibits certain discriminatory actions by manufacturers and requires importers to submit biannual reports on imported drugs.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (27)

Last Action

Referred to the Subcommittee on Health. (on 01/25/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...